Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PD 174265 is an effective, selective and reversible inhibitor of epidermal growth factor receptor (EGFR) with an IC50 of 0.45 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 50.00 | |
10 mg | In stock | $ 64.00 | |
25 mg | In stock | $ 95.00 | |
50 mg | In stock | $ 134.00 | |
100 mg | In stock | $ 194.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 63.00 |
Description | PD 174265 is an effective, selective and reversible inhibitor of epidermal growth factor receptor (EGFR) with an IC50 of 0.45 nM. |
Synonyms | PD174265, N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}propanamide, PD-174265 |
Molecular Weight | 371.23 |
Formula | C17H15BrN4O |
CAS No. | 216163-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (26.9mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PD 174265 216163-53-0 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR PD174265 N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}propanamide PD-174265 inhibitor inhibit